FDA Classifies Voriconazole Test System as Class II Device
May 09, 2025
May 09, 2025
WASHINGTON, May 9 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration (FDA) has issued a final order classifying the voriconazole test system into Class II (special controls), effective May 9, 2025.
This action aims to ensure the safety and effectiveness of the device while reducing regulatory burdens for manufacturers and improving patient access to innovative medical devices. The classification applies to devices intended for measuring voricon . . .
This action aims to ensure the safety and effectiveness of the device while reducing regulatory burdens for manufacturers and improving patient access to innovative medical devices. The classification applies to devices intended for measuring voricon . . .